MSX-130
MSX-130 is a CXCR4 antagonist. MSX-130 inhibits cancer metastasis[1].
Product Specifications
CAS Number
4051-59-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/msx-130.html
Purity
98.00
Solubility
DMSO : 2 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C1(C2=NC(C3=CC=CC=C3)=C(C4=CC=CC=C4)N2)=CC=C(C5=NC(C6=CC=CC=C6)=C(C7=CC=CC=C7)N5)C=C1
Molecular Formula
C36H26N4
Molecular Weight
514.62
Precautions
H302, H315, H319, H335
References & Citations
[1]Zhan W, et al. Discovery of small molecule CXCR4 antagonists. J Med Chem. 2007 Nov 15;50 (23) :5655-64.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA610309 100 µg
Dopamine Transporter Recombinant Chimeric Antibody Antibody
Sign In for Pricing
View Details 
BNC941372-500 1x 500 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1372), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details